Google AI has IQ of 47, about that of 1st-grader

Artificial intelligence (AI) has a long way to go before it outsmarts the average person, according to a report published in Annals of Data Science. The report aims to unite AI and human characteristics to improve overall knowledge of AI.

AI, while it may have many possible uses in healthcare, must be proven in knowledge before entering the care continuum. In this report, researchers examine the intelligence quotient IQ of AI systems including Google, Microsoft’s Bing, Baidu and Siri.

To evaluate the IQ of the AI platforms, researchers evaluaed the aspects of knowledge, input, output, mastery and creation. According to the report, in 2014, Google AI had the highest IQ of 26.5, followed by Baidu at 23.5. While these measurements are below the average IQ of a 6-year-old (55.5), 2016 evaluations showed improvement over time.

In 2016, Google’s AI was measuered to have an IQ of 47.28. Followed by Baidu at 32.9, Bing at 31.9 and SIRI at 23.9. While these aspects of knowledge still remain lower than a 6-year-old, the report shows significant growth. With the stride of technology and AI only gaining, researchers predict AIs’ IQ to continue to grow and eventually pass first-graders in knowledge.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.